Candel Therapeutics (CADL) had the highest return between March 22, 2024 and April 30, 2024 by a small-cap US stock, returning 373.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Candel Therapeutics (CADL) | 3/22/2024 - 4/30/2024 | 373.15% |
Avalo Therapeutics (AVTX) | 3/22/2024 - 4/30/2024 | 266.6% |
Canopy Growth (CGC) | 3/22/2024 - 4/30/2024 | 216.6% |
Mesoblast (MESO) | 3/22/2024 - 4/30/2024 | 192.04% |
Climb Bio (CLYM) | 3/22/2024 - 4/30/2024 | 142.81% |
Stewards Inc Common Stock (SWRD) | 3/22/2024 - 4/30/2024 | 127.27% |
Red Cat (RCAT) | 3/22/2024 - 4/30/2024 | 116.1% |
POET Technologies (POET) | 3/22/2024 - 4/30/2024 | 88.97% |
Stoke Therapeutics (STOK) | 3/22/2024 - 4/30/2024 | 83.53% |
New Pacific Metals (NEWP) | 3/22/2024 - 4/30/2024 | 74.78% |
SNDL (SNDL) | 3/22/2024 - 4/30/2024 | 72.73% |
Cullinan Oncology LLC (CGEM) | 3/22/2024 - 4/30/2024 | 64.29% |
Benitec Biopharma (BNTC) | 3/22/2024 - 4/30/2024 | 64.08% |
Nektar Therapeutics (NKTR) | 3/22/2024 - 4/30/2024 | 62.22% |
Village Farms International (VFF) | 3/22/2024 - 4/30/2024 | 56.12% |
Adlai Nortye Ltd American Depositary Shares (ANL) | 3/22/2024 - 4/30/2024 | 52.82% |
Zura Bio Limited - Class A Ordinary shares (ZURA) | 3/22/2024 - 4/30/2024 | 49.3% |
ProKidney (PROK) | 3/22/2024 - 4/30/2024 | 48.56% |
Hycroft Mining (HYMC) | 3/22/2024 - 4/30/2024 | 43.91% |
Janux Therapeutics (JANX) | 3/22/2024 - 4/30/2024 | 42.5% |
Galectin Therapeutics (GALT) | 3/22/2024 - 4/30/2024 | 42.11% |
Paysign (PAYS) | 3/22/2024 - 4/30/2024 | 41.54% |
MMTEC (MTC) | 3/22/2024 - 4/30/2024 | 40.54% |
Rezolute (RZLT) | 3/22/2024 - 4/30/2024 | 36.73% |
Phibro Animal Health (PAHC) | 3/22/2024 - 4/30/2024 | 35.99% |
Small-cap stocks are treated as having a market cap between $300M and $2B.